ISSN - 0973-0958

Pediatric Oncall Journal View Article

Spectrum of Renal Tubular Disorders in Iraqi Children
Aamir Jalal Al Mosawi.
Department of Pediatrics, University Hospital in Al Kadhimiyia, Iraq.
Objectives of study: The pattern of renal tubular disorder (RTDs) has been infrequently reported in the literature. In Germany, the three most frequent disorders were cystinosis, X-linked hypophosphatemic rickets (XLHR), and idiopathic hypercalciuria. This study was undertaken to determine the pattern of RTDs in Iraqi and Arab children.

Methods: From June 2000 to April 2007, 42 children with suspected RTD were evaluated to determine the type of tubulopathies.

Results: Ages at referral ranged from 8 months to 14 years (mean 4.8 years). There was evidence of RTD in only 37 patients; 23 males (62 %) and 14 females (38 %). Their ages at referral ranged between 8 months and 14 years (Mean 4.8 years). In 4 patients with oculo-cerebro-renal syndrome, there was no evidence of RTD and one patient has hyperoxaluria which was not a RTD. Seven types of RTDs were identified. The three most common disorders were: idiopathic hypercalciuria (35 %), cystinosis (21.6 %) and renal tubular acidosis RTA (21.6%) Four of the patients with RTA have proximal RTA, and four have distal RTA.Four of the patients with hypercalciuria have also significant hyperoxaluria > 3mg/kg/day.

Conclusion: Common RTDs in Iraqi children are idiopathic hypercalciuria, cystinosis and RTA and differs from those reported elsewhere.

Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0